Cervical Cancer News & Features
Women with cervical or endometrial cancer can safely receive extended-field intensity modulated radiation therapy (EF-IMRT) without increased risk of duodenal toxicity.
Fatalistic beliefs may affect completion of the human papillomavirus (HPV) vaccine series in some areas of the United States.
A decrease in cervical lesions among young women in the United States has been observed, but the cause for this drop is not proven.
Incidence of high-grade cervical lesions in young women has significantly decreased, but the declines were likely due to reduced screening.
One dose of the HPV vaccine may be sufficient to protect girls from cervical cancer rather than the currently recommended three doses.
Cervical Cancer Videos
Cervical Cancer Clinical Trials
- Likelihood of lung cancer screening update
- Universal health literacy precautions recommended to assist patient understanding
- In breast cancer survivors, lidocaine may relieve pain during intercourse
- Generic meds may boost survival in some early breast cancers
- Aromatase inhibitors substantially reduce risk of death in ER-positive breast cancer
- St. John's wort: natural does not necessarily mean safe
- No association between opioids, breast cancer recurrence
- Researchers, providers need to address cancer health care disparities in LGBTQ community
- New combination could make cancer more sensitive to chemotherapy
- New approach to treating B-cell acute lymphoblastic leukemia shows promise
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|